AGENTIX CORP.

AGTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014
Revenue $2.3K $43.1K $28.4K
Cost of Revenue $1.4K $1.4K $2.0K
Gross Profit $893 $41.8K $26.3K
Gross Margin 39.7% 96.9% 92.8%
Operating Expenses
Research & Development $3.7K $28.3K $61.7K
SG&A Expense $8.8K $23.7K $23.0K $36.3K $39.9K
Operating Income $-134.4K $-334.0K $-292.4K $-175.1K $-208.9K
Operating Margin -14,844.0% -677.8% -617.2%
Interest Expense $24.8K $13.3K
Pretax Income $-42.8M $-381.1K $-295.6K
Income Tax Expense
Net Income $-42.8M $-381.1K $-295.6K $-175.1K $-208.9K
Net Margin -16,937.8% -685.2% -617.2%
EPS (Basic) $-3,875.40 $-0.06 $-0.05 $-0.03 $-0.04
EPS (Diluted) $-3,875.40 $-0.06 $-0.05 $-0.03 $-0.04
Shares Outstanding (Basic) 20.6M 6.0M 6.0M 6.0M 5.9M
Shares Outstanding (Diluted) 20.6M 6.0M 6.0M 6.0M 5.9M
Dividends Per Share
← Newer Page 2 of 2 Older →